Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Paediatric SSRI use falls after US FDA warning

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Libby AM, Brent DA, Morrato EH, Orton HD, Allen R, Valuck RJ.Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. American Journal of Psychiatry 164: 884-891, No. 6, Jun 2007

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Paediatric SSRI use falls after US FDA warning. Pharmacoecon. Outcomes News 534, 6 (2007). https://doi.org/10.2165/00151234-200705340-00016

    Download citation

    Keywords

    • Public Health
    • Health Outcome
    • Paediatric Patient
    • Health Economic
    • Paediatric Population